
RNA right away
Spindle Biotech developed a proprietary RNA polymerase (RNAP) technology for large-scale mRNA manufacturing and gene editing research. The company used synthetic RNA instead of plasmid DNA to minimize off-target activity. Spindle was acquired by Applied DNA Sciences in July 2023, and its technology was integrated into the LineaIVT mRNA manufacturing platform.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountCreate a free account to see full funding history, valuations, and investor participation.
Create Free AccountCreate a free account to see which investors have funded this company.
Create Free Account